BioStem Technologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	37.65	47.48	301.83	16.69	6.88	4.34
Revenue Growth (YoY)	-88.67%	-84.27%	1708.93%	142.69%	58.38%	1284.88%
Cost of Revenue	4.57	3.04	13.75	1.26	0.88	1.47
Gross Profit	33.08	44.44	288.08	15.42	5.99	2.87
Selling, General & Admin	40.67	37.82	254.75	21.91	10.21	4.07
Research & Development	6.53	7.09	1.91	0.34	0.22	0.12
Operating Expenses	47.91	45.13	256.88	22.48	10.67	4.47
Operating Income	-14.82	-0.69	31.2	-7.06	-4.68	-1.61
Interest Expense	-	-	-0.59	-0.7	-0.47	-0.53
Interest & Investment Income	0.45	0.41	-	-	-	-
Other Non Operating Income (Expenses)	-0.12	-0.11	-	-0	0	0.03
EBT Excluding Unusual Items	-14.49	-0.39	30.61	-7.76	-5.15	-2.1
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.03
Legal Settlements	-	-	-	-0.72	-	-
Other Unusual Items	-	-	-	-	-2.08	0.66
Pretax Income	-14.49	-0.39	30.61	-8.48	-7.23	-1.41
Income Tax Expense	4.82	6.19	-1.27	-	-	-
Earnings From Continuing Operations	-19.31	-6.58	31.88	-8.48	-7.23	-1.41
Minority Interest in Earnings	-	-	-	-	0.04	-0.03
Net Income	-19.31	-6.58	31.88	-8.48	-7.19	-1.45
Net Income to Common	-19.31	-6.58	31.88	-8.48	-7.19	-1.45
Shares Outstanding (Basic)	17	17	16	14	11	12
Shares Outstanding (Diluted)	17	17	22	14	11	12
Shares Change (YoY)	-28.42%	-22.90%	58.30%	20.18%	-2.40%	130.37%
EPS (Basic)	-1.15	-0.39	1.95	-0.62	-0.63	-0.12
EPS (Diluted)	-1.15	-0.39	1.47	-0.62	-0.63	-0.12
Free Cash Flow	-	-	-	-3.6	0.06	-0.15
Free Cash Flow Per Share	-	-	-	-0.26	0.01	-0.01
Gross Margin	87.87%	93.59%	95.45%	92.44%	87.17%	66.03%
Operating Margin	-39.37%	-1.45%	10.34%	-42.30%	-68.09%	-36.99%
Profit Margin	-51.28%	-13.86%	10.56%	-50.84%	-104.62%	-33.30%
Free Cash Flow Margin	-	-	-	-21.60%	0.87%	-3.51%
EBITDA	-14.11	-0.46	31.41	-6.83	-4.46	-1.32
EBITDA Margin	-37.47%	-0.97%	10.41%	-40.93%	-64.86%	-30.45%
D&A For EBITDA	0.72	0.23	0.21	0.23	0.22	0.28
EBIT	-14.82	-0.69	31.2	-7.06	-4.68	-1.61
EBIT Margin	-39.37%	-1.45%	10.34%	-42.30%	-68.09%	-36.99%
Advertising Expenses	-	-	-	0.2	0.09	0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.